Trial intelligence / Profile preview

Synera in Patellar Tendinopathy

NCT01111773Phase 2Completed

Sponsor
ZARS Pharmaceuticals
Start
Jun 2010
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of lidocaine + tetracaine in patellar tendinopathy, sponsored by ZARS Pharmaceuticals. Started Jun 2010; status: completed.

02

Drugs

lidocaine + tetracaine
03

Conditions

patellar tendinopathy

Beyond the preview

Go deeper on NCT01111773.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01111773.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call